Fingerprint
Dive into the research topics of 'The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically